192 related articles for article (PubMed ID: 25079197)
21. Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx2.
Sun J; Zhou H; Deng Y; Zhang Y; Gu P; Ge S; Fan X
Cells Tissues Organs; 2012; 196(6):510-22. PubMed ID: 22906827
[TBL] [Abstract][Full Text] [Related]
22. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity.
Vidal MA; Kilroy GE; Johnson JR; Lopez MJ; Moore RM; Gimble JM
Vet Surg; 2006 Oct; 35(7):601-10. PubMed ID: 17026544
[TBL] [Abstract][Full Text] [Related]
23. Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.
Reagan MR; Mishima Y; Glavey SV; Zhang Y; Manier S; Lu ZN; Memarzadeh M; Zhang Y; Sacco A; Aljawai Y; Shi J; Tai YT; Ready JE; Kaplan DL; Roccaro AM; Ghobrial IM
Blood; 2014 Nov; 124(22):3250-9. PubMed ID: 25205118
[TBL] [Abstract][Full Text] [Related]
24. Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
Basile A; Moschetta M; Ditonno P; Ria R; Marech I; De Luisi A; Berardi S; Frassanito MA; Angelucci E; Derudas D; Specchia G; Curci P; Pavone V; Rossini B; Ribatti D; Bottazzi B; Mantovani A; Presta M; Dammacco F; Vacca A
J Pathol; 2013 Jan; 229(1):87-98. PubMed ID: 22847671
[TBL] [Abstract][Full Text] [Related]
25. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
27. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
28. Osteogenic differentiation and angiogenesis with cocultured adipose-derived stromal cells and bone marrow stromal cells.
Kim KI; Park S; Im GI
Biomaterials; 2014 Jun; 35(17):4792-804. PubMed ID: 24655782
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
[TBL] [Abstract][Full Text] [Related]
30. Osteogenic stem cells and the stromal system of bone and marrow.
Beresford JN
Clin Orthop Relat Res; 1989 Mar; (240):270-80. PubMed ID: 2645077
[TBL] [Abstract][Full Text] [Related]
31. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
Guang LG; Boskey AL; Zhu W
Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
[TBL] [Abstract][Full Text] [Related]
32. A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.
Gunn WG; Conley A; Deininger L; Olson SD; Prockop DJ; Gregory CA
Stem Cells; 2006 Apr; 24(4):986-91. PubMed ID: 16293576
[TBL] [Abstract][Full Text] [Related]
33. Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering.
Ciapetti G; Ambrosio L; Marletta G; Baldini N; Giunti A
Biomaterials; 2006 Dec; 27(36):6150-60. PubMed ID: 16965811
[TBL] [Abstract][Full Text] [Related]
34. [Culture and regulation of osteoblasts in multiple myeloma patients].
Gao S; Fu R; Liu H; Liu H; Song J; Wang H; Wang G; Xing L; Shao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):202-6. PubMed ID: 24666484
[TBL] [Abstract][Full Text] [Related]
35. Demineralized bone matrix mediates differentiation of bone marrow stromal cells in vitro: effect of age of cell donor.
Becerra J; Andrades JA; Ertl DC; Sorgente N; Nimni ME
J Bone Miner Res; 1996 Nov; 11(11):1703-14. PubMed ID: 8915778
[TBL] [Abstract][Full Text] [Related]
36. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis.
Dalle Carbonare L; Valenti MT; Zanatta M; Donatelli L; Lo Cascio V
Arthritis Rheum; 2009 Nov; 60(11):3356-65. PubMed ID: 19877060
[TBL] [Abstract][Full Text] [Related]
37. Carfilzomib promotes the osteogenic differentiation potential of mesenchymal stem cells derived from myeloma patients by inhibiting notch1 activity in vitro.
Li Y; Li J; Zhuang W; Wang Q; Ge X; Zhang X; Chen P; Fu J; Li B
Leuk Res; 2014 Aug; 38(8):970-6. PubMed ID: 24939218
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Xu S; Menu E; De Becker A; Van Camp B; Vanderkerken K; Van Riet I
Stem Cells; 2012 Feb; 30(2):266-79. PubMed ID: 22102554
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells cultured on a collagen scaffold: In vitro osteogenic differentiation.
Donzelli E; Salvadè A; Mimo P; Viganò M; Morrone M; Papagna R; Carini F; Zaopo A; Miloso M; Baldoni M; Tredici G
Arch Oral Biol; 2007 Jan; 52(1):64-73. PubMed ID: 17049335
[TBL] [Abstract][Full Text] [Related]
40. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources.
Stockmann P; Park J; von Wilmowsky C; Nkenke E; Felszeghy E; Dehner JF; Schmitt C; Tudor C; Schlegel KA
J Craniomaxillofac Surg; 2012 Jun; 40(4):310-20. PubMed ID: 21723141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
